IFI-K · Propionamide Analog

Specimen SS-F-KOK-941 // KOKUMI · IFI-K

Propionamide Analog III-PR-A

Saccharomyces cerevisiae

Yeast

Tier IIIPropionamide Analog

Target Trait

1.95×

fold-change

Glutathione-analog amide CaSR kokumi fold-change in Saccharomyces cerevisiae

Technical Specifications

SKU

SS-F-KOK-941

Genomic Edits

5

GC Content

45.1%

Construct Length

3,190 bp

Promoter System

Ubiquitin / T7

Expression System

Protoplast PEG-fusion

Host Strain

PEG-4000

Receptor Target

CaSR (calcium-sensing receptor)

IFI Score

195

Pathway Edits

  • BAHD-AT (BAHD acyltransferase) expression for propionyl group transfer to GSH scaffold
  • GCL substrate supply for γ-glutamyl-cysteinyl scaffold production as BAHD-AT acceptor
  • GS-alt (alternative glutathione synthetase) expression for amide bond formation on analog scaffold
  • AAT (amino acid acetyltransferase) expression for amide bond optimization in analog structure
  • Amide-GSH analog permease expression for cytosolic accumulation of CaSR-active analog

Key Interventions

BAHD-AT acyltransferase expression for propionamide-GSH analog biosynthesis as CaSR kokumi ligandGCL/GS-alt γ-glutamyl-cysteinyl scaffold supply for BAHD-AT-catalyzed acyl modificationAAT amide bond formation optimization for structurally constrained CaSR analog engagementProtoplast PEG-fusion delivery optimized for Saccharomyces cerevisiae genome accessibilityTier-III construct validated with 5 precision edits for 1.95× fold-change

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
195
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Commercial yeast propionamide analog extract for specialty fermented food and beverage kokumi

License

$1499 · Tier III License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Kokumi · IFI-KAll Modalities